Gyrodyne, LLC reduces board size, agrees with Star Equity Fund to promote governance and shareholder value at 2025 meeting.
Quiver AI Summary
Gyrodyne, LLC has announced a new agreement with Star Equity Fund, LP, resulting in the withdrawal of Star Equity's nominees for the 2025 annual shareholders meeting and a reduction of Gyrodyne’s board size from five to four directors. The board will freeze director compensation and cap the Chairman's fee at $65,000. Richard Smith will be the sole nominee for election at the upcoming meeting. The agreement, which also includes standstill provisions from Star Equity, highlights Gyrodyne’s commitment to improving governance and shareholder value. Gyrodyne's leadership expressed appreciation for the collaboration with Star Equity and acknowledged Paul Lamb's 28 years of service as a key contributor to the company. The full agreement will be detailed in a Current Report to the SEC.
Potential Positives
- The agreement with Star Equity Fund signifies a collaborative approach to governance, reflecting Gyrodyne's commitment to constructive shareholder engagement.
- The reduction in board size and freeze on director compensation may lead to improved operational efficiency and cost management.
- The nomination of Richard Smith as the sole candidate for the board enhances clarity and focus for the upcoming shareholder meeting.
- Gyrodyne's acknowledgment of Paul Lamb's service highlights its commitment to recognizing leadership contributions, which may bolster investor confidence in the company's stability and continuity.
Potential Negatives
- Reduction of the board size from five to four directors may signal internal governance issues or lack of confidence in the board's effectiveness.
- Freezing director compensation and limiting the Chairman's fee may indicate financial strain or dissatisfaction among shareholders regarding executive pay structures.
- Star Equity Fund's withdrawal of its nominees suggests potential dissatisfaction with the company's current leadership, raising questions about the effectiveness of existing management.
FAQ
What changes were announced regarding Gyrodyne's board of directors?
Gyrodyne will reduce its board size from five to four directors and freeze director compensation.
Who is the sole nominee for the 2025 annual shareholders meeting?
Richard Smith will be the sole nominee standing for election at the 2025 annual shareholders meeting.
What was the agreement with Star Equity Fund?
Star Equity Fund withdrew its nominees and agreed to standstill provisions as part of the agreement with Gyrodyne.
How does this agreement affect shareholder engagement?
The agreement reflects Gyrodyne’s commitment to strengthen governance and enhance transparency for its shareholders.
What is Gyrodyne's business focus?
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties in the New York metropolitan area.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$GYRO Insider Trading Activity
$GYRO insiders have traded $GYRO stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $GYRO stock by insiders over the last 6 months:
- LLC TOWERVIEW has made 0 purchases and 2 sales selling 3,189 shares for an estimated $39,474.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GYRO Hedge Fund Activity
We have seen 0 institutional investors add shares of $GYRO stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMCO INVESTORS, INC. ET AL removed 840 shares (-5.5%) from their portfolio in Q2 2025, for an estimated $7,229
- TETON ADVISORS, INC. removed 300 shares (-1.7%) from their portfolio in Q2 2025, for an estimated $2,582
- UBS GROUP AG removed 39 shares (-3.9%) from their portfolio in Q2 2025, for an estimated $335
- CERITY PARTNERS LLC added 0 shares (+0.0%) to their portfolio in Q2 2025, for an estimated $0
- GABELLI FUNDS LLC added 0 shares (+0.0%) to their portfolio in Q2 2025, for an estimated $0
- GABELLI & CO INVESTMENT ADVISERS, INC. added 0 shares (+0.0%) to their portfolio in Q2 2025, for an estimated $0
- CSS LLC/IL added 0 shares (+0.0%) to their portfolio in Q2 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
ST. JAMES, N.Y., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gyrodyne, LLC (Nasdaq: GYRO), an owner and manager of a diversified portfolio of real estate properties (“Gyrodyne”), today announced that it has entered into an agreement (the “Agreement”) with Star Equity Fund, LP (“Star Equity Fund”), under which Star Equity Fund has withdrawn its slate of nominees for election at the 2025 annual shareholders meeting, and Gyrodyne will reduce the size of its board from five to four directors, freeze director compensation and limit the aggregate fee paid to the Chairman to $65,000. In connection with the reduction in board size, Richard Smith will be the sole nominee standing for election at the 2025 annual shareholders meeting.
Star Equity has also agreed to certain customary standstill provisions. The full agreement with Star Equity will be filed in a Current Report on Form 8-K with the Securities and Exchange Commission.
The agreement with Star Equity Fund reflects Gyrodyne’s continued commitment to constructive engagement with shareholders as part of its ongoing efforts to strengthen governance, enhance transparency and drive long-term value creation for all shareholders.
Gary Fitlin, Gyrodyne’s President and Chief Executive Officer, stated that “We appreciate the thoughtful input from Star Equity and our broader shareholder base. Their perspectives have strengthened our efforts as we work toward completing the sale of our properties and delivering maximum value to our shareholders.”
Jeff Eberwein, manager of Star Equity Fund, added that “Following the most recent constructive discussions with the company, we are pleased to have worked collaboratively with the Board to enhance governance and further align with shareholders’ interests”.
Nader Salour, Chairman of Gyrodyne’s Nominating Committee, also added: “On behalf of the entire company and Board of Directors, I want to express our deep gratitude to Paul Lamb for his extraordinary 28 years of service to Gyrodyne. His steady leadership and strategic vision have been instrumental in guiding the company through periods of tremendous challenge and transformation. Paul Lamb leaves behind a lasting legacy of integrity and a steadfast commitment to our stakeholders. While he will not be standing for re-election at the upcoming shareholders’ meeting, as a significant shareholder he will continue to be an important voice and valued supporter of the company’s long-term success. We thank him for his many contributions and wish him the very best in the years ahead.”
About Gyrodyne, LLC
Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. The Company owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York, both of which are the subject of plans to seek value-enhancing entitlements. The Company’s common shares are traded on the NASDAQ Stock Market under the symbol GYRO. Additional information about the Company may be found on its web site at www.gyrodyne.com .
Forward-Looking Statements
The statements made in this press release that are not historical facts constitute "forward-looking information" within the meaning of the Private Securities Litigation Reform Act of 1995, and Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, both as amended, which can be identified by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "projects," "estimates," "believes," "seeks," "could," "should," or "continue," the negative thereof, other variations or comparable terminology as well as statements regarding the evaluation of strategic alternatives. Important factors, including certain risks and uncertainties, with respect to such forward-looking statements that could cause actual results to differ materially from those reflected in such forward-looking statements include, but are not limited to, risks and uncertainties generally relating to our efforts to enhance the values of our remaining properties and seek the orderly, strategic sale of such properties as soon as reasonably practicable, risks associated with the Article 78 Proceeding against the Company and any other litigation that may develop in connection with our efforts to enhance the value of and sell our properties, risks relating to our national marketing campaign led by JLL for the sale of our Flowerfield and Cortlandt Manor properties, risks associated with our purchase and sale agreement with B2K (and future purchase and sale agreements for our remaining properties that may be contingent on years-long regulatory contingencies) in light of our financial condition, community activism risk, proxy contests and other actions of activist shareholders, regulatory enforcement risk, risks inherent in the real estate markets of Suffolk and Westchester Counties in New York, the potential residual effects of the COVID-19 pandemic, lingering risks relating to the 2023 banking crisis and closure of two major banks (including one with whom we indirectly had a mortgage loan which the FDIC transferred in December 2023 to a new holder following the banks closure), ongoing inflation risk, ongoing interest rate uncertainty, recession uncertainty and supply chain constraints or disruptions, and other risks detailed from time to time in Gyrodyne’s SEC reports.
Contact:
Gary Fitlin
Chief Executive Officer
Gyrodyne, LLC
Phone: (631) 584-5400
[email protected]
https://www.gyrodyne.com